Non-genetic cardiac rhythm disease

Non-genetic cardiac rhythm disease (Orphanet code 218439) is a classification category encompassing cardiac arrhythmias that arise from non-hereditary causes rather than from identifiable genetic mutations. These conditions affect the heart's electrical conduction system, leading to abnormal heart rhythms (arrhythmias) that can manifest as the heart beating too fast (tachycardia), too slow (bradycardia), or irregularly. Unlike inherited channelopathies or familial arrhythmia syndromes, these rhythm disturbances are acquired and may result from structural heart disease, ischemic injury, inflammatory or infectious processes (such as myocarditis), metabolic derangements, drug toxicity, or other environmental and systemic factors. Key symptoms can include palpitations, dizziness, lightheadedness, syncope (fainting), chest discomfort, shortness of breath, and in severe cases, cardiac arrest or sudden cardiac death. The clinical presentation varies widely depending on the specific type of arrhythmia and its underlying cause. Diagnosis typically involves electrocardiography (ECG), Holter monitoring, electrophysiological studies, and evaluation for underlying structural or metabolic causes. Treatment depends on the specific arrhythmia and its etiology and may include antiarrhythmic medications, rate-controlling drugs, catheter ablation procedures, implantation of pacemakers or cardioverter-defibrillators (ICDs), and management of the underlying condition. Addressing reversible causes such as electrolyte imbalances, thyroid dysfunction, or drug effects is a critical component of therapy. This is a broad grouping category within Orphanet rather than a single discrete disease entity, which means clinical features, prognosis, and management strategies vary considerably across the conditions encompassed within this classification.

Common questions about Non-genetic cardiac rhythm disease